Northwest Biotherapeutics, Inc. Share Price
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1640 USD | -0.61% |
|
-4.48% | -28.32% |
| Market Cap | 28Cr 24Cr 22Cr 21Cr 39Cr 2.64TCr 39Cr 264.04Cr 103.63Cr 1.32TCr 103.97Cr 101.69Cr 4.41TCr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 37Cr 32Cr 30Cr 28Cr 52Cr 3.56TCr 53Cr 355.68Cr 139.59Cr 1.77TCr 140.06Cr 136.98Cr 5.94TCr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 10.3x |
| Free-Float |
95.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.61% | ||
| 1 week | -4.48% | ||
| 1 month | -12.21% | ||
| 3 months | -17.17% | ||
| 6 months | -43.62% | ||
| Current year | -28.32% |
| 1 week | 0.16 | 0.18 | |
| 1 month | 0.14 | 0.2 | |
| Current year | 0.14 | 0.34 | |
| 1 year | 0.14 | 0.37 | |
| 3 years | 0.14 | 1.09 | |
| 5 years | 0.14 | 2.05 | |
| 10 years | 0.14 | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 01/06/2007 |
Linda Powers
CEO | Chief Executive Officer | 71 | 08/06/2011 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/01/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 01/01/1998 |
Linda Powers
CHM | Chairman | 71 | 17/05/2007 |
Navid Malik
BRD | Director/Board Member | 57 | 01/04/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/08/24 | Don | Founder | 10,00,000 | 0.0826% | ||
| 09/08/24 | Don | Chief Technology Officer | 30,00,000 | 0.2478% | ||
| 08/08/24 | Don | Founder | 10,00,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.61% | -4.48% | -32.87% | -69.03% | 28Cr | ||
| +2.35% | +2.74% | +33.41% | +79.20% | 5.65TCr | ||
| -0.21% | -7.38% | +25.34% | +63.02% | 5.36TCr | ||
| -2.44% | +1.40% | -15.74% | -16.80% | 2.29TCr | ||
| -2.85% | -7.78% | -8.09% | +346.36% | 2.14TCr | ||
| +2.49% | -0.92% | +20.31% | -12.15% | 2.03TCr | ||
| +0.79% | -1.06% | +29.29% | -33.32% | 1.76TCr | ||
| +0.58% | -5.88% | +16.30% | +540.37% | 1.47TCr | ||
| -5.25% | -4.23% | +46.41% | +169.05% | 1.33TCr | ||
| +3.41% | -6.61% | +163.08% | +280.43% | 1.35TCr | ||
| Average | -0.17% | -3.86% | +27.74% | +134.71% | 2.34TCr | |
| Weighted average by Cap. | +0.23% | -2.96% | +28.60% | +119.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 3.89Cr 3.38Cr 3.15Cr 2.89Cr 5.46Cr 371.67Cr 5.55Cr 37Cr 15Cr 185.03Cr 15Cr 14Cr 620.44Cr |
| Net income | - | - |
| Net Debt | 9.61Cr 8.35Cr 7.77Cr 7.14Cr 13Cr 917.17Cr 14Cr 92Cr 36Cr 456.61Cr 36Cr 35Cr 1.53TCr | 12Cr 11Cr 10Cr 9.28Cr 18Cr 1.19TCr 18Cr 119.16Cr 47Cr 593.76Cr 47Cr 46Cr 1.99TCr |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | $0.1640 | -0.61% | 12,61,005 |
| 30/26/30 | $0.1650 | +1.85% | 20,11,696 |
| 29/26/29 | $0.1620 | -5.48% | 23,03,171 |
| 28/26/28 | $0.1714 | -1.27% | 21,67,426 |
| 27/26/27 | $0.1736 | +1.12% | 17,09,184 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1640USD
Average target price
1.000USD
Spread / Average Target
+509.76%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
















